Open Access Open Access  Restricted Access Subscription or Fee Access

Computational Software Assisted Multiple Therapeutic Targets Oriented Screening of Some Natural Alkaloid Compounds

TOMY MURINGAYIL JOSEPH, DEBARSHI KAR MAHAPATRA

Abstract


The current efforts endeavor towards the computational exploration of some interesting
pharmacological potentials of some natural alkaloids by using the Schrodinger Maestro 9.1
software. The excellence in therapeutics was screened against five most imperative targets:
Cyclin-Dependent Kinase-5 (anti-cancer), Cycloxygenase-2 (anti-inflammatory), Protein
kinase C (anti-cancer), Dipeptidyl peptidase (anti-diabetic), and Angiotensin-1-Converting
Enzyme (anti-hypertensive). The alkaloids which were previously reported to possess
antibiotic activities against Bacillus subtilis, Staphylococcus aureus, and Mycobacterium
smegmatis and anti-photo-oxidative, have now perceived to be multi-dimensional compounds
with better pharmacodynamics expression. From the obtained impressive Glide score for the
compounds against the biological target and the dock poses featuring the formation of strong
hydrogen bonding, π-π interactions, and Van der Waals forces through -NH and -OH groups
with several amino acid residues, eventually concluded anti-cancer, anti-diabetic, and antiinflammatory
activities in newer contexts. A new angle of therapeutic excellence can be
noticed from this validated computational study which in larger context rejuvenates and opens
better perspectives for researchers, academicians, and modern scientists towards the
development of dual inhibitors in future. The study explored new applications of various
natural products and has recently developed a perception towards the development of multitargeted
ligands that are not restricted to only one therapeutic response.
Keywords: Alkaloid, molecular docking, in silico, therapeutic target, multi-targeted, inhibitors


Keywords


Alkaloid, Molecular docking, In silico, Therapeutic target, Multi-targeted, Inhibitors

Full Text:

PDF

References


Mahapatra DK, Bharti SK, Asati V. Chalcone derivatives: Anti-inflammatory potential and molecular targets perspectives. Curr Top Med Chem. 2017;17(28):3146–69p.

Chhajed SS, Bastikar V, Bastikar AV, Mahapatra DK. Computer Aided Drug Design, 1st Edn. Pune: Everest Publishing House; 2019.

Mahapatra DK, Bharti SK, editors. Pharmacological Perspectives of Low Molecular Weight Ligands, 1st Edn. New Jersey: Apple Academic Press; 2019.

Chhajed SS, Upasani C, Wadher SJ, Mahapatra DK. Medicinal Chemistry, 1st Edn. Nashik: Career Publications Private Limited; 2017.

Mahapatra DK, Bharti SK. Drug Design, 1st Edn. New Delhi, India: Tara Publications Private Limited; 2016.

Mahapatra DK, Bharti SK. Handbook of Research on Medicinal Chemistry: Innovations and Methodologies, 1st Edn. New Jersey: Apple Academic Press; 2017.

Mahapatra DK, Bharti SK. Medicinal Chemistry with Pharmaceutical Product Development, 1st Edn. New Jersey: Apple Academic Press; 2019.

Joseph TM, Mahapatra DK. Bacterial DNA Gyrase (Topoisomerase) Inhibitory Potentials of Heterocyclic Natural Products: Investigations through Induced-Fit Molecular Docking Approach. Res Rev J Drug Des Discov. 2018;5(2):7-9p.

Joseph TM, Mahapatra DK. Induced-Fit Molecular Docking and Pharmacokinetic Prediction Studies of Two Phenanthrene Compound Series as Potential Cyclooxygenase-2 (COX-2) and Lipoxygenase (LOX) Inhibitors: Edema Reducing Prospects of the Emerging Candidates. Res Rev Journal Bioinformat. 2018;5(3):1-8p.

Joseph TM, Mahapatra DK. A Nascent Step towards the Discovery of New Generation Non-Steroidal Anti-inflammatory Agents (NSAIDs): Induced-Fit Molecular Docking and Pharmacokinetic Prediction Studies of Some Chromene Derivatives as Potential Cyclooxygenase-2 (COX-2) and Lipoxygenase (LOX) Inhibitors. Res Rev J Boinformat. 2018;5(2):30-36p.


Refbacks

  • There are currently no refbacks.